|
1
|
Mazidimoradi A, Momenimovahed Z, Allahqoli L, Tiznobaik A, Hajinasab N, Salehiniya H, Alkatout I. The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer. Health Sci Rep 2022; 5:e936. [DOI: 10.1002/hsr2.936] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Revised: 10/07/2022] [Accepted: 11/02/2022] [Indexed: 11/24/2022] Open
Affiliation(s)
| | | | | | - Azita Tiznobaik
- Department of Midwifery and Reproductive Health, Mother and Child Care Research Center, School of Nursing and Midwifery Hamadan University of Medical Sciences Hamadan Iran
| | - Negar Hajinasab
- Student Research Committee Iran University of Medical Sciences (IUMS) Tehran Iran
| | - Hamid Salehiniya
- Social Determinants of Health Research Center Birjand University of Medical Sciences Birjand Iran
| | - Ibrahim Alkatout
- Kiel School of Gynaecological Endoscopy, University Hospitals Schleswig‐Holstein Kiel Germany
| |
Collapse
|
|
2
|
Zhang S, Cheng C, Lin Z, Xiao L, Su X, Zheng L, Mu Y, Liao M, Ouyang R, Li W, Ma J, Cai J, Liu L, Wang D, Zeng F, Liu J. The global burden and associated factors of ovarian cancer in 1990-2019: findings from the Global Burden of Disease Study 2019. BMC Public Health 2022; 22:1455. [PMID: 35907822 PMCID: PMC9339194 DOI: 10.1186/s12889-022-13861-y] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2022] [Accepted: 07/22/2022] [Indexed: 11/10/2022] Open
Abstract
Background Ovarian cancer (OC) is a major cause of cancer-related deaths among women. The aim of this study was to estimate and report data on the current burden of ovarian cancer worldwide over the past 30 years. Method Based on the data provided by GBD 2019, we collected and interpreted the disease data of ovarian cancer by incidence, mortality, disability-adjusted life-years (DALYs), and used corresponding age-standardized rates as indicators. Also, we categorized the data by attributed risk factors and captured deaths due to high fasting plasma glucose, occupational exposure to asbestos and high body-mass index, respectively. All outcomes in the study were reported using mean values and corresponding 95% uncertainty intervals (95% UI). Results Globally, there were 294422 (260649 to 329727) incident cases in 2019, and the number of deaths and DALYs were 198412 (175357 to 217665) and 5.36 million (4.69 to 5.95). The overall burden was on the rise, with a percentage change of 107.8% (76.1 to 135.7%) for new cases, 103.8% (75.7 to 126.4%) for deaths and 96.1% (65.0 to 120.5%) for DALYs. Whereas the age-standardized rates kept stable during 1990–2019. The burden of ovarian cancer increased with age. and showed a totally different trends among SDI regions. Although high SDI region had the declining rates, the burden of ovarian cancer remained stable in high-middle and low SDI regions, and the middle and low-middle SDI areas showed increasing trends. High fasting plasma glucose was estimated to be the most important attributable risk factor for ovarian cancer deaths globally, with a percentage change of deaths of 7.9% (1.6 to 18.3%), followed by occupational exposure to asbestos and high body mass index. Conclusions Although the age-standardized rates of ovarian cancer didn’t significantly change at the global level, the burden still increased, especially in areas on the lower end of the SDI range. Also, the disease burden due to different attributable risk factors showed heterogeneous, and it became more severe with age. Supplementary Information The online version contains supplementary material available at 10.1186/s12889-022-13861-y.
Collapse
Affiliation(s)
- Shiwen Zhang
- Department of Public Health and Preventive , of Medicine, Jinan University, Guangzhou, China
| | - Chen Cheng
- Department of Public Health and Preventive , of Medicine, Jinan University, Guangzhou, China
| | - Zejian Lin
- Department of Public Health and Preventive , of Medicine, Jinan University, Guangzhou, China
| | - Linzi Xiao
- Department of Public Health and Preventive , of Medicine, Jinan University, Guangzhou, China
| | - Xin Su
- Department of Public Health and Preventive , of Medicine, Jinan University, Guangzhou, China
| | - Lu Zheng
- Department of Public Health and Preventive , of Medicine, Jinan University, Guangzhou, China
| | - Yingjun Mu
- Department of Public Health and Preventive , of Medicine, Jinan University, Guangzhou, China
| | - Minqi Liao
- Department of Public Health and Preventive , of Medicine, Jinan University, Guangzhou, China
| | - Ruiqing Ouyang
- Department of Public Health and Preventive , of Medicine, Jinan University, Guangzhou, China
| | - Wanlin Li
- Department of Public Health and Preventive , of Medicine, Jinan University, Guangzhou, China
| | - Junrong Ma
- Department of Public Health and Preventive , of Medicine, Jinan University, Guangzhou, China
| | - Jun Cai
- Department of Public Health and Preventive , of Medicine, Jinan University, Guangzhou, China
| | - Lu Liu
- Department of Preventive Medicine Laboratory, School of Public Health, Zunyi Medical University, Zunyi, China
| | - Donghong Wang
- Department of Gynaecology and Obstetrics, Affiliated Hospital of Zunyi Medical University, Guizhou, China
| | - Fangfang Zeng
- Department of Public Health and Preventive , of Medicine, Jinan University, Guangzhou, China.
| | - Jun Liu
- Department of Preventive Medicine Laboratory, School of Public Health, Zunyi Medical University, Zunyi, China.
| |
Collapse
|